Breakthrough science. One moment, one day, one person at a time.

Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, operating as an independent Subsidiary of multinational company, Roche holding. It became an independent subsidiary of Roche in 2009.

Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.

The little things we do every day add up to big breakthroughs. Making a difference in the lives of millions starts when you make a change in yours.

Genentech has multiple medicines for serious and life-threatening medical conditions. Access information and resources on each of our medicines

9 小时之前 · About Genentech. Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. ...

10 小时之前 · SOUTH SAN FRANCISCO, Calif., April 03, 2025--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that new data were presented at the AD/PD 2025 International ...

9 小时之前 · (RTTNews) - Genentech, a Roche Group member (RHHBY.OB), Thursday presented new findings at the AD/PD 2025 International Conference in Vienna, highlighting advancements in Alzheimer's and Parkinson ...

2025年3月4日 · Genentech’s new stroke drug is delivered as a single five-second intravenous (IV) bolus, whereas Activase is administered as an IV bolus followed by a one-hour infusion. The differences in administration come down to TNKase’s longer half-life and higher fibrin specificity. Genentech said it will also introduce a new 25mg vial configuration ...

Genentech | 798,026 followers on LinkedIn. About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions.